| T754 |
0-526 |
Sentence |
denotes |
Chen et al. (2020) [6] Randomized, parallel-group clinical trial62 patients suffering from COVID-19 HCQ group -> 400 mg/day HCQControl group -> SOCDay 5 Body temperature recovery time in the HCQ group was shorter than the control group (2.2 vs. 3.2 days, p = 0.0008).Cough remission time was significantly decreased in the HCQ group (2.0 vs. 3.1 days, p = 0.0016).Improvement of pneumonia in HCQ group (80.6% vs. 54.8%)Pneumonia absorption in HCQ group (61.3%) One patient developed a rash.One patient reported a headache. |
